ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 58 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $815,000 | -59.4% | 264,900 | -49.2% | 0.08% | -68.0% |
| Q4 2015 | $2,008,000 | +104.9% | 521,700 | +63.8% | 0.26% | +101.6% |
| Q3 2015 | $980,000 | +351.6% | 318,500 | +464.7% | 0.13% | +323.3% |
| Q1 2015 | $217,000 | -1.8% | 56,400 | +173.8% | 0.03% | -41.2% |
| Q3 2013 | $221,000 | -77.0% | 20,600 | -80.1% | 0.05% | -80.2% |
| Q2 2013 | $962,000 | – | 103,700 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |